| P2093 | author name string | Wilfried Budach | |
| | Pirus Ghadjar | |
| | Christiane Matuschek | |
| | Edwin Bölke | |
| | Klaus Orth | |
| | Jan Haussmann | |
| P2860 | cites work | Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies | Q24651894 |
| | MicroRNA expression characterizes oligometastasis(es) | Q27311314 |
| | DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. | Q27851466 |
| | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 |
| | An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. | Q30828791 |
| | Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial | Q31065424 |
| | Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial | Q33614301 |
| | Prophylactic cranial irradiation in extensive small-cell lung cancer | Q34005742 |
| | Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib | Q34163370 |
| | Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study | Q34521660 |
| | Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 |
| | Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial | Q34656647 |
| | The evolutionary history of lethal metastatic prostate cancer | Q35548366 |
| | Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). | Q36278103 |
| | Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancer | Q36422709 |
| | Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients | Q36757904 |
| | Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? | Q36783402 |
| | Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature | Q38139680 |
| | Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | Q38409259 |
| | Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937. | Q38709731 |
| | The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis. | Q38788767 |
| | Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). | Q39371669 |
| | Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study | Q39675331 |
| | Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT). | Q39749392 |
| | Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. | Q43665987 |
| | Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment | Q45152949 |
| | Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease | Q45170619 |
| | A prospective study of surgical procedures for patients with oligometastatic non-small cell lung cancer | Q46223896 |
| | Long-term Outcome of Surgery or Stereotactic Radiotherapy for Lung Oligometastases | Q47873061 |
| | Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. | Q47931888 |
| | The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. | Q48092999 |
| | Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). | Q48375192 |
| | Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients | Q48609781 |
| | Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer | Q48762033 |
| | Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial | Q49039293 |
| | A randomized trial of surgery in the treatment of single metastases to the brain | Q49096659 |
| | Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy? | Q50802743 |
| | Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison. | Q52630845 |
| | Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial. | Q53045959 |
| | Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. | Q53311270 |
| | Oligometastases. | Q55065168 |
| | Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. | Q55070432 |
| | Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. | Q55235302 |
| | Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial | Q56768701 |
| | 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)† | Q56910818 |
| | Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q57051777 |
| | Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial | Q57812646 |
| | Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non-small-cell Lung Cancer (NSCLC) | Q57821629 |
| | Efficacy of Local Consolidative Therapy for Oligometastatic Lung Adenocarcinoma Patients Harboring Epidermal Growth Factor Receptor Mutations | Q57821630 |
| | EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases | Q58616450 |
| | Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease | Q60946509 |
| | Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years | Q64095015 |
| | Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer | Q71261788 |
| | Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases | Q73649115 |
| | Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study | Q86629441 |
| | Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs | Q88934250 |
| | Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer | Q90024663 |
| | Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer | Q91158930 |
| | Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma | Q91259360 |
| | Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial | Q91515397 |
| | Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study | Q91852299 |
| | Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinica | Q91855403 |
| | Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis | Q92073236 |
| | Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study | Q92454578 |
| | Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report | Q92526381 |
| | Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients | Q93077867 |
| P433 | issue | 50 | |
| P304 | page(s) | 849-856 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Deutsches Ärzteblatt international | Q27722165 |
| P1476 | title | The Role of Local Treatment in Oligometastatic and Oligoprogressive Cancer | |
| P478 | volume | 116 | |